GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+16.74%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.4B
AUM Growth
-$147M
(-5.8%)
Cap. Flow
-$273M
Cap. Flow
% of AUM
-11.39%
Top 10 Holdings %
Top 10 Hldgs %
28.1%
Holding
209
New
22
Increased
53
Reduced
105
Closed
29
Top Buys
| 1 |
MRX
Marex Group
MRX
|
$29.8M |
| 2 |
KLC
KinderCare Learning Companies, Inc.
KLC
|
$25.7M |
| 3 |
Sweetgreen
SG
|
$21.3M |
| 4 |
Archer Aviation
ACHR
|
$20.7M |
| 5 |
Sportradar
SRAD
|
$16.1M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$43.6M |
| 2 |
Zeta Global
ZETA
|
$39.7M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
$33.3M |
| 4 |
Chart Industries
GTLS
|
$30.4M |
| 5 |
Toast
TOST
|
$25.6M |
Sector Composition
| 1 | Technology | 34.89% |
| 2 | Industrials | 16.58% |
| 3 | Healthcare | 15.75% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
FTAI Aviation
FTAI
$16B
| $8.47M | 0.35% |
+58,790
| New | +$8.47M |
|
77
Edgewise Therapeutics
EWTX
$1.54B
| $8.01M | 0.33% |
300,013
-211,892
| -41% | -$5.66M |
|
78
Norwegian Cruise Line
NCLH
$11.6B
| $7.63M | 0.32% |
+296,707
| New | +$7.63M |
|
79
LoveSac
LOVE
$291M
| $7.58M | 0.32% |
320,558
-156,300
| -33% | -$3.7M |
|
|
80
Chart Industries
GTLS
$8.96B
| $7.5M | 0.31% |
39,289
-159,122
| -80% | -$30.4M |
|
81
PTC
PTC
$25.5B
| $7.5M | 0.31% |
40,766
-16,660
| -29% | -$3.06M |
|
82
Vita Coco
COCO
$2.12B
| $7.47M | 0.31% |
202,419
-454,013
| -69% | -$16.8M |
|
83
MoonLake Immunotherapeutics
MLTX
$3.79B
| $7.39M | 0.31% |
136,438
-36,196
| -21% | -$1.96M |
|
84
PROS Holdings
PRO
$727M
| $7.34M | 0.31% |
334,355
-174,226
| -34% | -$3.83M |
|
85
JFrog
FROG
$5.65B
| $7.18M | 0.3% |
244,057
-76,768
| -24% | -$2.26M |
|
86
Xenon Pharmaceuticals
XENE
$2.98B
| $7.15M | 0.3% |
182,333
-18,544
| -9% | -$727K |
|
87
Lattice Semiconductor
LSCC
$9.03B
| $7.08M | 0.3% |
124,941
+29,015
| +30% | +$1.64M |
|
88
Pliant Therapeutics
PLRX
$100M
| $6.94M | 0.29% |
527,147
-211,105
| -29% | -$2.78M |
|
89
Qualys
QLYS
$4.85B
| $6.67M | 0.28% |
47,549
-28,501
| -37% | -$4M |
|
90
FIVE9
FIVN
$2.03B
| $6.65M | 0.28% |
163,657
-39,789
| -20% | -$1.62M |
|
91
Veeco
VECO
$1.44B
| $6.53M | 0.27% |
243,669
-48,095
| -16% | -$1.29M |
|
92
Stoke Therapeutics
STOK
$1.08B
| $6.26M | 0.26% |
567,689
-77,281
| -12% | -$852K |
|
93
Varonis Systems
VRNS
$6.24B
| $6.09M | 0.25% |
137,005
-9,227
| -6% | -$410K |
|
94
CCC Intelligent Solutions
CCCS
$6.29B
| $6.07M | 0.25% |
517,180
-90,806
| -15% | -$1.07M |
|
95
CorVel
CRVL
$4.41B
| $6.05M | 0.25% |
54,366
-17,067
| -24% | -$1.9M |
|
96
Zymeworks
ZYME
$1.07B
| $6.02M | 0.25% |
411,120
-202,383
| -33% | -$2.96M |
|
|
ITCI
97
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.83M | 0.24% |
69,841
-29,693
| -30% | -$2.48M |
|
98
Silicon Laboratories
SLAB
$4.43B
| $5.77M | 0.24% |
46,463
-12,130
| -21% | -$1.51M |
|
99
Vital Farms
VITL
$2.31B
| $5.7M | 0.24% |
151,347
+51,942
| +52% | +$1.96M |
|
100
Quanterix
QTRX
$201M
| $5.7M | 0.24% |
536,417
-566,214
| -51% | -$6.02M |
|